English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Thursday, March 28, 2024
Press Releases for Tuesday, February 11, 2020
AIM ImmunoTech提交了三項有關安普利近(R) 的臨時專利申請,以用於對抗類似SARS的武漢2019年新型冠狀病毒
19:30 HKT/SGT
AIM ImmunoTech提交了三项有关安普利近(R) 的临时专利申请,以用于对抗类似SARS的武汉2019年新型冠状病毒
19:30 HKT/SGT
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus
19:30 HKT/SGT
BH Global, Penguin International, Strategic Partners sign MoU to Develop Singapore's first Hybrid Electric Marine Launch
16:00 HKT/SGT
Combined data approach could accelerate development of new materials
16:00 HKT/SGT
知临集团宣布其用于治疗由金黄色葡萄球菌所引起的感染的ALS-4小分子抗毒力(非杀菌)候选药物的进一步正面资料,并可望于2020年下半年提交IND
15:50 HKT/SGT
知臨集團宣布其用於治療由金黃色葡萄球菌所引起的感染的ALS-4小分子抗毒力(非殺菌)候選藥物的進一步正面資料,並可望於2020年下半年提交IND
15:49 HKT/SGT
知临集团宣布用于神经母细胞瘤的再利用候选药物SACT-1取得显著进展并计划2020下半年提交IND
15:41 HKT/SGT
知臨集團宣布用於神經母細胞瘤的再利用候選藥物SACT-1取得顯著進展並計畫2020下半年提交IND
15:40 HKT/SGT
Novel approach from Synergy Pharmaceuticals may hold cure to herpes virus
15:30 HKT/SGT
Aptorum Group Announces Further Positive Data for its ALS-4 Small Molecule Anti-virulence (Non-bactericidal) Drug Candidate for Treatment of Infections caused by Staphylococcus Aureus
11:14 HKT/SGT
NetDragon's Multiple Online Education Products Support Continuous Online Learning amid No-School Period
10:20 HKT/SGT
网龙旗下网教通等多款在线教育产品助力千万师生“停课不停学”
09:04 HKT/SGT
網龍旗下網教通等多款在線教育產品助力千萬師生「停課不停學」
09:03 HKT/SGT
NetDragon's Multiple Online Education Products Support Continuous Online Learning amid No-School Period
09:01 HKT/SGT
ACN Search:
2024 Australian IT Journalism Awards Winners Announced
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575